Trials / Completed
CompletedNCT06111963
Role of Inflammatory Markers in Sepsis
Role of Inflammatory Markers Measured Using Flow Cytometry in the Diagnosis and Prognosis of Sepsis in Surgical Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serology tests | CD4, CD25, IL17 |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2025-01-05
- Completion
- 2025-01-25
- First posted
- 2023-11-01
- Last updated
- 2025-07-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06111963. Inclusion in this directory is not an endorsement.